CIK: 0001582384 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 14, 2017
Total Value ($000): $217,438 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KITE PHARMA INC | 2,358,084 | $105,736 | 48.6% | $57.67 | — | COM | 49803L109 |
| CSGP | COSTAR GROUP INC | 195,117 | $36,778 | 16.9% | $16.16 | +21.6% | COM | 22160N109 |
| — | NANTKWEST INC | 4,485,495 | $25,657 | 11.8% | $11.46 | — | COM | 63016Q102 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,799,790 | $13,719 | 6.3% | $12.08 | -50.3% | COM NEW | 83587F202 |
| MDXG | MIMEDX GROUP INC | 1,080,365 | $9,572 | 4.4% | $8.80 | +2.1% | COM | 602496101 |
| — | BARCLAYS BK PLC | 320,600 | $8,179 | 3.8% | $25.51 | — | CALL | 06740Q902 |
| LPLA | LPL FINL HLDGS INC | 206,647 | $7,276 | 3.3% | $43.12 | -18.9% | COM | 50212V100 |
| — | COMMUNICATIONS SALES&LEAS IN | 163,000 | $4,142 | 1.9% | $25.41 | — | COM | 20341J104 |
| — | ISHARES TR | 10,400 | $2,760 | 1.3% | $265.38 | — | CALL | 464287906 |
| — | NANTHEALTH INC | 238,828 | $2,374 | 1.1% | $12.47 | — | COM | 630104107 |
| EDIT | EDITAS MEDICINE INC | 41,324 | $671 | 0.3% | $26.29 | -42.3% | COM | 28106W103 |
| IBB | ISHARES TR | 1,719 | $456 | 0.2% | $289.43 | — | NASDQ BIOTEC ETF | 464287556 |
| NTLA | INTELLIA THERAPEUTICS INC | 3,542 | $46 | 0.0% | $15.02 | 0.0% | COM | 45826J105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 15,000 | $44 | 0.0% | $2.93 | — | COM | 00773U108 |
| GM | GENERAL MTRS CO | 800 | $28 | 0.0% | $28.16 | 0.0% | COM | 37045V100 |